Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
2.8
-125.82%
40%
—
-87.44%
40%
—
5 Years
Score2.8
Net Growth-125.82%
Net Trend40%
Net Income Consistency—
Rev Growth-87.44%
Rev Trend40%
Revenue Consistency—
Moderna Inc fundamental performance
Between 2020 and 2025, revenue grew from $ 274M to $ 1.94B and net income went from -$ 747M to -$ 2.82B. Revenue increased in 2 of those 5 years; net income in 2.
Moderna Inc currently holds a 5-year HDB Score of 2.8 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 63.67 | — |
1 Year2025-08-12 | $ 25.66 | 148.13% |
5 Years2021-08-12 | $ 391.42 | -83.73% |
All Time2018-12-07 | $ 18.60 | 242.31% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2018-12-07 |
|---|---|---|---|---|
| Price | $ 63.67 | $ 25.66 | $ 391.42 | $ 18.60 |
| Return | — | 148.13% | -83.73% | 242.31% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 2.22B | -$ 3.15B | $ 1.72B |
| 2025 | $ 1.94B | -$ 2.82B | $ 5.79B |
| 2024 | $ 3.19B | -$ 3.56B | $ 7.02B |
| 2023 | $ 6.84B | -$ 4.71B | $ 8.60B |
| 2022 | $ 18.87B | $ 8.36B | $ 9.90B |
| 2021 | $ 17.73B | $ 12.20B | $ 10.72B |
| 2020 | $ 274M | -$ 747M | $ 4.60B |
| 2019 | $ 48M | -$ 514M | $ 1.10B |
| IPO2018 | $ 122M | -$ 384M | $ 1.69B |
Explore beyond MRNA
You're looking at Moderna Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
